Le centre hospitalier intercommunal Robert-Ballanger est un hôpital des communes d'Aulnay-sous-Bois, du Blanc-Mesnil, de Sevran, de Tremblay-en-France et de Villepinte, en Seine-Saint-Denis. Il est situé à Villepinte, bien que son nom initial soit centre hospitalier d'Aulnay-sous-Bois.

During the past decade, Centre Hospital General Robert Ballanger conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre Hospital General Robert Ballanger" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 2 trials, followed by "Assistance Publique - Hôpitaux de Paris" with 1 trials sponsored, "CMC Ambroise Paré" with 1 trials sponsored, "Celgene" with 1 trials sponsored and "Centre Hospitalier Intercommunal Robert Ballanger" with 1 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Hospital General Robert Ballanger" #1 collaborator was "CMC Ambroise Paré" with 1 trials as a collaborator, "Centre Hospitalier Intercommunal Montfermeil-Le Raincy" with 1 trials as a collaborator, "Centre Hospitalier Intercommunal Robert Ballanger" with 1 trials as a collaborator, "Groupe Hospitalier Pitie-Salpetriere" with 1 trials as a collaborator and "Lymphoma Study Association" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Centre Hospital General Robert Ballanger" are "Breast Cancer" (2 trials), "ARDS" (1 trials), "Arthritis, Rheumatoid" (1 trials), "Autism" (1 trials) and "Autism Spectrum Disorder" (1 trials). Many other conditions were trialed in "Centre Hospital General Robert Ballanger" in a lesser frequency.

Most popular intervention types in "Centre Hospital General Robert Ballanger" are "Drug" (7 trials), "Other" (4 trials), "Biological" (2 trials), "Device" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "epirubicin hydrochloride" (3 trials), "radiation therapy" (2 trials), "vinblastine sulfate" (2 trials), "ABVD regimen" (1 trials) and "BEACOPP regimen" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre Hospital General Robert Ballanger" are 17 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Centre Hospital General Robert Ballanger". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Centre Hospital General Robert Ballanger, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Centre Hospital General Robert Ballanger, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".